Vagal nerve block for weight loss in metastatic pancreatic cancer
Part of Cancer clinical trials.
This trial tests a device that blocks a nerve in the neck to see if it helps treat weight loss (cachexia) caused by pancreatic cancer. The goal is to help patients maintain or gain weight while continuing cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have pancreatic cancer that has spread (metastatic) and is confirmed to have adenocarcinoma cells.
- You have lost at least 5% of your body weight since your diagnosis.
- Your cancer has worsened after at least one previous treatment for the spread, and you are about to start another treatment.
- You do not have certain heart rhythm problems, like an irregular heartbeat or a prolonged QT interval.
- You have not had surgery or structural issues on the right side of your neck that would prevent placing the device.
- You do not have a recent history of stroke, severe heart disease, or metal implants in the neck.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a non-invasive device that uses low-level radio waves to standard chemotherapy (gemcitabine and nab-paclitaxel) can help people with pancreatic cancer that has spread to other parts of the body.
This Phase 2 trial tests whether a device that delivers carefully timed “radiofrequency heat” through the body can slow or control metastatic (spread) pancreatic cancer. You may qualify if you have newly diagnosed metastatic pancreatic cancer and can meet safety and blood-test requirements.
This trial tests if a nerve block can help control pain after gastric bypass or sleeve gastrectomy. The goal is to reduce the need for strong pain medicines and improve recovery.
This trial tests whether an early nerve block during endoscopy can better control pain from pancreatic cancer compared to waiting and using standard treatments.
This trial tests a new form of a drug (nano-megestrol acetate) to help people with advanced pancreatic cancer who are losing weight and have poor appetite. It aims to see if it can improve cachexia, a condition of severe weight loss and muscle wasting.
This trial tests a non-invasive device that stimulates a nerve in your ear to help prevent nausea caused by chemotherapy. It is for people with breast cancer who are about to start a specific type of chemo (anthracycline and cyclophosphamide).
Hear when a new Metastatic Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.